je.st
news
AstraZeneca in $560 m deal for respiratory firm
2013-06-10 15:26:14| Biotech - Topix.net
British drugmaker AstraZeneca PLC says it is to acquire Pearl Therapeutics Inc., a Redwood-City, California-based company involved in therapies for asthma and chronic obstructive pulmonary disease for at least $560 million.
Tags: deal
firm
respiratory
astrazeneca
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||